Processing your payment...
Please do not close your browser.

Human Growth Hormone Market - Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players - Novo Nordisk, Pfizer, Eli Lilly, Merck Serono

02 Jan, 2020 | 121 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Registering a CAGR of 8.61% over the forecast period of 2022-2027, the human growth hormone market is anticipated to reach the market value of US$ 7,567.74 million in the year 2027 from US$ 4,632.54 million in the year 2022.



Human Growth Hormone Market Overview



The human growth hormone which is also known as somatotropin is a peptide hormone which is secreted by pituitary gland that regulates cell regeneration and repair, metabolism, reproduction and cell growth which contributes to complete human growth. Growth hormone levels in the human body are supposed to be suitable for normal growth and those can be controlled by elements like sleep, stress, exercise and low glucose levels. These hormones also help regulate muscle & bone growth, body composition, sugar & fat metabolism, body fluids and recovery from injury.



In humans, the deficiency of hormone is caused by pituitary glands that do not create enough concentration of human growth hormones. This particular deficiency can be treated by managing recombinant human growth hormones by subcutaneous injection. Several genetic disorders like turner syndrome and Prader-Willi syndrome can cause this deficiency too which can lead to shorter-than-average height and delayed puberty.



Who are the Major Players in Human Growth Hormone Market?



Top Key players in the Human Growth Hormone Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Human Growth Hormone Market is fragmented with a large number of small players operating worldwide. The companies referred in the market research report includes Novo Nordisk, Pfizer Inc. (NYSE:PFE), Eli Lilly and Company (NYSE:LLY), Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology and others.



Industry News and Updates:



November 2020, GenSci (GenScience Pharmaceuticals), entered an exclusive agreement with Foresee Pharmaceuticals, for commercializing the latter’s FP-001 program, LMIS (Leuprolide Mesylate Injectable Suspension) –subcutaneous, ready-to-use 3-month and 6-month depot formulations or Camcevi. This agreement will be solely focusing on the Chinese market.



November 2020, Aeterna collaborated with Novo Nordisk, with the aim to boost the application scope of macimorelin that helps diagnose growth hormone deficiency, which is childhood-onset. The company believes that this area is considerably untapped and therefore, desires to explore the unmet needs. Aeterna is currently in the early stage of clinical safety as well as efficacy study, which focuses on analyzing Macimorelin for detection of CGHD.



What are the major Applications, Types and Regions for Human Growth Hormone Market?



Human Growth Hormone Market is segmented based on the type, applications, companies and regions.



By Type, Human Growth Hormone Market has been segmented into 




  • Powder

  • Solvent



By Application, Human Growth Hormone Market has been segmented into 




  • Growth Hormone Deficiency

  • Idiopathic Short Stature

  • Small for Gestational Age

  • Turner Syndrome

  • Prader-Willi Syndrome



Regional Analysis of Human Growth Hormone Market:



Because of variables such as attractive reimbursement scenarios, established healthcare infrastructure, major government initiatives, and expanding healthcare awareness, North America is expected to account for the greatest share. Furthermore, the North American market benefits from enhanced access to novel medications due to the presence of important competitors in the region. Pfizer, Inc., Eli Lilly and Company, and Genentech, Inc. are some of the leading US-based competitors in the region, offering a wide range of human GH medicines.

Over the forecast period, Asia Pacific is expected to grow at a high rate. By acquiring permission and launching fresh goods, key companies aim to gain a significant market share in Asia Pacific potential countries such as Japan and China. For example, Novo Nordisk A/S, a Danish pharmaceutical company, began a phase III clinical trial of their HGH somapacitan, which is used to treat adult growth hormone insufficiency, in March 2017.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





What is our Human Growth Hormone Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 8.61% during the review period (2022 to 2027).



By Type




  • Powder

  • Solvent



By Application




  • Growth Hormone Deficiency

  • Idiopathic Short Stature

  • Small for Gestational Age

  • Turner Syndrome

  • Prader-Willi Syndrome



By Companies



Novo Nordisk, Pfizer Inc. (NYSE:PFE), Eli Lilly and Company (NYSE:LLY), Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology and others.



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



121



Customization Available



Yes, the report can be customized as per your needs




Key Takeaways from this Human Growth Hormone Report




  • Evaluate Human Growth Hormone market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.

  • Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Human Growth Hormone market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.



Frequently Asked Questions



What is the study period of this market?



The Human Growth Hormone Market is studied from 2017 - 2027.



What is the growth rate of Human Growth Hormone Market?



The Human Growth Hormone Market is growing at a CAGR of 8.61% over the next 5 years.



Who are the leading key players in Human Growth Hormone Market?



Novo Nordisk, Pfizer Inc. (NYSE:PFE), Eli Lilly and Company (NYSE:LLY), Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology and others.



What regions regions does this Human Growth Hormone Market report covers?



North America (the United States, Canada, and Mexico)



Europe (Germany, France, UK, Russia, and Italy)



Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)



South America (Brazil, Argentina, Colombia, etc.)



The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



What are the significant types of Human Growth Hormone Market?



Powder, Solvent



What are the significant Applications of Human Growth Hormone Market?



Growth Hormone Deficiency, Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome



All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL HUMAN GROWTH HORMONE MARKET BY TYPES

    3. GLOBAL HUMAN GROWTH HORMONE MARKET BY APPLICATIONS



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR HUMAN GROWTH HORMONE



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. HUMAN GROWTH HORMONE GROWTH

      2. APPLICATION OF HUMAN GROWTH HORMONE



    4. IMPACT OF COVID 19



  5. GLOBAL HUMAN GROWTH HORMONE MARKET, BY TYPES

    1. INTRODUCTION

    2. POWDER

    3. SOLVENT

    4.  OTHERS



  6. GLOBAL HUMAN GROWTH HORMONE MARKET, BY APPLICATION

    1. INTRODUCTION

    2. GROWTH HORMONE DEFICIENCY

    3. IDIOPATHIC SHORT STATURE

    4. SMALL FOR GESTATIONAL AGE

    5. TURNER SYNDROME

    6. PRADER-WILLI SYNDROME

    7.  OTHERS



  7. GLOBAL HUMAN GROWTH HORMONE MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. NOVO NORDISK

      2. PFIZER

      3. ELI LILLY

      4. MERCK SERONO

      5. F. HOFFMANN-LA ROCHE

      6. FERRING PHARMACEUTICALS

      7. GENESCIENCE PHARMACEUTICALS

      8. IPSEN

      9. LG LIFE SCIENCES

      10. SANDOZ INTERNATIONAL

      11. ANHUI ANKE BIOTECHNOLOGY







 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 3M
  • 3M
  • 9